I. H. Krakoff
- Co-authors
- S. M. LippmanJ. J. KavanaghPatricia Paredes-CasillasM. Paredes-EspinozaW. K. HongWaun Ki HongRandal S. WeberMark A. Schusterman
- Topics
- Cancer Treatment and Pharmacology (3 papers)Radiopharmaceutical Chemistry and Applications (2 papers)Cancer therapeutics and mechanisms (2 papers)
- Cited by
- BiochemistryDermatologyOncology
- Journals
- Journal of Clinical OncologyAnnals of Internal MedicineJNCI Journal of the National Cancer Institute
- Partner nations
- United StatesSwitzerlandMexico
In The Last Decade
I. H. Krakoff
13 papers receiving 705 citations
Peers
Comparison fields: 5 of 70
- Molecular Biology 445
- Oncology 203
- Genetics 142
- Immunology 124
- Epidemiology 123
Countries citing papers authored by I. H. Krakoff
This map shows the geographic impact of I. H. Krakoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. H. Krakoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. H. Krakoff more than expected).
Fields of papers citing papers by I. H. Krakoff
This network shows the impact of papers produced by I. H. Krakoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. H. Krakoff. The network helps show where I. H. Krakoff may publish in the future.
Co-authorship network of co-authors of I. H. Krakoff
This figure shows the co-authorship network connecting the top 25 collaborators of I. H. Krakoff. A scholar is included among the top collaborators of I. H. Krakoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. H. Krakoff. I. H. Krakoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 2 | |
| 3 | 76 | |
| 4 | 305 | |
| 5 | 259 | |
| 6 | 5 | |
| 7 | 2 | |
| 8 | 13 | |
| 9 | Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck. | 3 |
| 10 | Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomas. | 19 |
| 11 | Water-soluble N-substituted iminodiacetato(1,2-diaminocyclohexane)-platinum(II) complexes as potential antitumor agents. | 25 |
| 12 | Continuous-infusion spirogermanium for the treatment of refractory carcinoma of the ovary: a phase II trial. | 5 |
| 13 | Phase I evaluation of piperazinedione in patients with advanced cancer. | 1 |
| 14 | 33 |
About I. H. Krakoff
I. H. Krakoff is a scholar working on Oncology, Small Animals and Cancer Research, having authored 14 papers that have together received 755 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cancer therapeutics and mechanisms (2 papers). The work is most often cited by research in Biochemistry (99 citations), Dermatology (109 citations) and Oncology (203 citations). I. H. Krakoff has collaborated with scholars based in United States, Switzerland and Mexico. Frequent co-authors include S. M. Lippman, J. J. Kavanagh, Patricia Paredes-Casillas, M. Paredes-Espinoza, W. K. Hong, Waun Ki Hong, Randal S. Weber, Mark A. Schusterman, Loretta M. Itri and Stimson P. Schantz. Their work appears in journals such as Journal of Clinical Oncology, Annals of Internal Medicine and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.